Retention and its predictors among methadone maintenance treatment clients in China: A six-year cohort study

Drug and Alcohol Dependence

Volumn 145, Issue , 2014, Pages 87-93

  Cao, Xiaobin ^a   Wu, Zunyou ^a   Rou, Keming ^a   Li, Li ^b   Lin, Chunqing ^b   Wang, Changhe ^a   Luo, Wei ^a   Pang, Lin ^a   Yin, Wenyuan ^a   Li, Jianhua ^c  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Yunnan Institute of Drug Abuse   (China)

^d Key lab of biological evaluation of medical devices of Shandong province   (China)

Author keywords

Cohort study; Methadone maintenance treatment; Retention; Risk factor

Indexed keywords

METHADONE; MORPHINE;

ADULT; ARTICLE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; DRUG ADMINISTRATION; DRUG MEGADOSE; DRUG URINE LEVEL; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OBSERVATIONAL STUDY; OPEN STUDY; OPIATE ADDICTION; PATIENT COMPLIANCE; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; TREATMENT DURATION; CLINICAL TRIAL; DRUG DEPENDENCE TREATMENT; MEDICATION COMPLIANCE; MULTICENTER STUDY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; TIME; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADULT; CHINA; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84921844517     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.09.776     Document Type: Article

References (29)

1. Ball J.C., Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome 1991, Springer-Verlag, New York, NY.
2. Bell J., Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review. Drug Alcohol Rev. 2006, 25:167-171.
3. Cao X.B., Wu Z.Y. Methadone maintenance treatment as an HIV prevention strategy: a research update. Chin. J. STD AIDS 2011, 17:196-199.
4. Cao X.B., Wu Z.Y., Li L., Pang Lin Rou K.M., Wang C.H., Luo W., Yin W.Y., Li J.H., McGoogan J.M. Mortality among methadone maintenance clients in China: a six-year cohort study. PLoS One 2013, 8:e82476.
5. Cao X.B., Wu Z.Y., Pang L., Rou K.M., Wang C.H., Luo W., Yin W.Y., Mi G.D., Li J.H. Evaluation on the long-term effectiveness among the first eight methadone maintenance treatment clinics in China. Chin. J. Epidemiol. 2012, 33:879-882.
6. China Ministry of Health, Ministry of Public Security, The State Food and Drug Administration Implementation Protocol of the Community-based Methadone Maintenance Treatment Program for Opiate Addicts in China 2006, China Ministry of Health, Beijing, China.
7. China Ministry of Health, UNAIDS, WHO 2011 Estimates for the HIV/AIDS Epidemic in China 2011, China Ministry of Health, Beijing, China.
8. Gowing L., Farrell M.F., Bornemann R., Sullivan L.E., Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst. Rev. 2011, 8:CD004145.
9. Joseph H., Stancliff S., Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt. Sinai J. Med. 2000, 67:347-364.
10. Kelly S.M., O'Grady K.E., Brown B.S., Mitchell S.G., Schwartz R.P. The role of patient satisfaction in methadone treatment. Am. J. Drug Alcohol Abuse 2010, 36:150-154.
11. Kerr T., Marsh D., Li K. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend. 2005, 80:329-335.
12. Li L., Wu Z.Y., Cao X.B. Provider-client interaction in methadone treatment clinics in China. J. Drug Issues 2012, 42:147-155.
13. Lin C.Q., Wu Z.Y., Detels R. Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health 2011, 125:269-274.
14. Lin C.Q., Wu Z.Y., Rou K.M., Pang L., Cao X.B., Shoptaw S., Detels R. Challenges in providing services in methadone maintenance therapy clinics in China: service providers' perceptions. Int. J. Drug Policy 2010, 21:173-178.
15. Liu E.W., Liang T., Shen L.M., Zhong H., Wang B., Wu Z.Y., Detels R. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int. J. Drug Policy 2009, 20:304-308.
16. Mao Y.R., Wu Z.Y., Poundstone K., Wang C.H., Qin Q.Q., Ma Y., Ma W. Development of a unified web-based national HIV/AIDS information system in China. Int. J. Epidemiol. 2010, 39(Suppl. 2):ii79-ii89.
17. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 1993, 6:1049-1056.
18. Metzger D.S., Woody G.E., O'Brien C.P. Drug treatment as HIV prevention: a research update. J. Acquir. Immune Defic. Syndr. 2010, 55(Suppl. 1):S32-S36.
19. National Narcotic Control Commission Annual Report on Drug Control in China (2014) 2014, National Narcotic Control Commission, Beijing, China.
20. Pang L., Hao Y., Mi G.D., Wang C.H., Luo W., Rou K.M., Li J.H., Wu Z.Y. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007, 21(Suppl. 8):S103-S107.
21. Peles E., Schreiber S., Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J. Addict. Dis. 2006, 25:43-50.
22. Qian H.Z., Schumacher J.E., Chen H.T., Ruan Y.H. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct. J. 2006, 3:4.
23. Simpson D.D., Joe G.W., Rowan-Szal G.A., Greener J.M. Drug abuse treatment process components that improve retention. J. Subst. Abuse Treat. 1997, 14:565-572.
24. State Council AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China 2004, State Council AIDS Working Committee Office, Beijing, China.
25. Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
26. Ward J., Mattick R.P., Hall W. Methadone Maintenance Treatment and Other Opioid Replacement Therapies 1998, Harwood Academic Publishers, Amsterdam.
27. Wong K.H., Lee S.S., Lim W.L., Low H.K. Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J. Subst. Abuse Treat. 2003, 24:233-239.
28. Wu Z.Y., Sullivan S.G., Wang Y., Rotheram-Borus M.J., Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007, 369:679-690.
29. Yin W.Y., Hao Y., Sun X.H., Gong X.L., Li F., Li J.H., Rou K.M., Sullivan S.G., Wang C.H., Cao X.B., Luo W., Wu Z.Y. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int. J. Epidemiol. 2010, 39(Suppl. 2):ii29-ii37.